id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-N-0040-0003,FDA,FDA-2006-N-0040,Draft Regulatory Action for Review to OMB and OIRA re: Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use Part 2 of 2,Supporting & Related Material,Background Material,2007-11-13T05:00:00Z,2007,11,,,2016-02-24T15:33:16Z,,0,0,0900006480442293
FDA-2006-N-0040-0002,FDA,FDA-2006-N-0040,Draft Regulatory Action for Review to OMB and OIRA re: Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use Part 1 of 2,Supporting & Related Material,Background Material,2007-11-13T05:00:00Z,2007,11,,,2016-02-24T15:32:22Z,,0,0,0900006480442292
FDA-2006-N-0040-0001,FDA,FDA-2006-N-0040,Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2007-11-08T05:00:00Z,2007,11,2007-11-08T05:00:00Z,2008-02-07T04:59:59Z,2016-02-18T16:00:48Z,,0,0,0900006480442290